[建立和优化Helicobacter pylori的常规耐药性测试,以鼓励耐药性导向治疗]
Anke Hildebrandt1,2, Reinhard Bornemann3,4
1Medizinische Klinik I, St. Vincenz-Krankenhaus, Datteln, Germany.
概括
杆菌的抗生素耐药性需要超越实证治疗. 耐药性测试指导个性化治疗,提高疗效,促进抗生素管理,以获得更好的患者结果.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 传统上,Helicobacter pylori感染的治疗依赖于经验性抗生素治疗方案.
- 越来越多的抗生素耐药性和不同的区域性耐药性模式挑战了标准疗法的有效性.
- 抗生素管理原则强调需要更有针对性的治疗方法.
研究的目的:
- 评估对H. pylori感染的耐药性测试和耐药性导向治疗的适当性.
- 强调个性化治疗策略对实证方法的好处.
- 倡导将耐药性测试纳入常规H. pylori诊断中.
主要方法:
- 对H.pylori感染的当前治疗策略的审查.
- 讨论抗生素耐药性测试的作用,包括基于培养和PCR方法.
- 在胃镜检查的背景下,对可用的诊断选择进行分析.
主要成果:
- 经验性抗生素疗法因耐药性增加而变得越来越不有效.
- 耐药性测试允许选择最佳的,个性化的治疗方案.
- 耐药导向疗法提高了治疗的有效性,并支持抗生素管理.
结论:
- 针对H. pylori的耐药性测试对于面对不断发展的耐药性而进行有效治疗至关重要.
- 与实证治疗相比,个性化,抵抗导向治疗提供了一个更合适和更有效的方法.
- 将耐药性测试整合到诊断协议中对于优化H. pylori管理至关重要.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.2K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
541
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
541
Peptic Ulcer Disease IV: Management
440
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
440
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543


